Thanks @davybabyk,
It was an excellent interview to explain immunotherapy in Cancer, the ethical issues in conducting trials in Asia (not to mention prevalence of gastric cancers). Will we be seeing extension of early 2019 Ph 2 with extra trial sites in the USA? Particularly on yesterday’s non price sensitive announcement. $23 million cap raising completed last year ...roll on IMU with your brilliant work. GLTAH
New Paul Hopper Interview, page-2
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
0.002(5.26%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.8¢ | 4.0¢ | 3.7¢ | $606.5K | 15.64M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 117506 | 3.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.0¢ | 1949086 | 9 |
View Market Depth
| Last trade - 16.10pm 27/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
